These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1491386)

  • 21. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.
    Newman ED; Perruquet JL; Harrington TM
    J Rheumatol; 1991 Sep; 18(9):1379-82. PubMed ID: 1684619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.
    Cutolo M
    Scand J Rheumatol Suppl; 2011; 125():17-22. PubMed ID: 21529306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alkaline phosphatase activity in granulocytes of patients with rheumatoid arthritis treated intermittently with nitrogen mustard].
    Guja A; Wycislo-Guja E
    Wiad Lek; 1971 Jul; 24(13):1245-8. PubMed ID: 5094450
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease.
    Cimmino MA; Innocenti S; Livrone F; Magnaguagno F; Silvestri E; Garlaschi G
    Arthritis Rheum; 2003 May; 48(5):1207-13. PubMed ID: 12746893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered memory T cell differentiation in patients with early rheumatoid arthritis.
    Skapenko A; Wendler J; Lipsky PE; Kalden JR; Schulze-Koops H
    J Immunol; 1999 Jul; 163(1):491-9. PubMed ID: 10384153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts.
    Calvo FA; Calvo A; Berrocal A; Pevez C; Romero F; Vega E; Cusi R; Visaga M; De La Cruz RA; Alarcón GS
    J Rheumatol; 1999 Mar; 26(3):536-9. PubMed ID: 10090158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with selected synovial T cells in rheumatoid arthritis.
    Chen G; Li N; Zang YC; Zhang D; He D; Feng G; Ni L; Xu R; Wang L; Shen B; Zhang JZ
    Arthritis Rheum; 2007 Feb; 56(2):453-63. PubMed ID: 17265481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis].
    Lashina NIu; Solov'ev SK; Balabanova RM
    Ter Arkh; 2000; 72(5):28-31. PubMed ID: 11109615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.
    Wendling D; Wijdenes J; Racadot E; Morel-Fourrier B
    J Rheumatol; 1991 Mar; 18(3):325-7. PubMed ID: 1713269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
    Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
    Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longterm treatment of rheumatoid arthritis with OM-8980. A retrospective study.
    Rosenthal M; Bahous I; Ambrosini G
    J Rheumatol; 1991 Dec; 18(12):1790-3. PubMed ID: 1795313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The importance of administration of a series of methylprednisolone minipulses in the treatment of active rheumatoid arthritis].
    Hrncír Z
    Cas Lek Cesk; 1994 Jul; 133(14):440-2. PubMed ID: 8069902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of immunosuppressive therapy with nitrogen mustard on serum concentration of immunoglobulins, C-3 component of complement and alpha-1-antitrypsin in patients with rheumatoid arthritis].
    Chwal Z
    Pol Tyg Lek; 1976 Apr; 31(14):561-3. PubMed ID: 1083974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.